SEC EDGAR CompanyFacts fact · point in time
SIMCERE PHARMACEUTICAL GROUP: xbrl:Cash
One fact, its scope and the complete path back to the official record.
Reported value
$28.597M{"amount": 28597000, "currency": "USD"}- Metric
- xbrl:Cash
- Period
- as of 2012-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T13:20:59.469552+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…History
- supersedes {"unit": "CNY", "value": 178162000} (evidence 0001104659-13-033291)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.